期刊文献+

脓毒症患者凝血系统功能紊乱的研究 被引量:3

Study of Coagulation Dysfunctions in The Patients with Sepsis
下载PDF
导出
摘要 目的:探讨脓毒症患者凝血功能紊乱与病情严重程度及预后的关系。方法:将2005年6月至2006年12月入住我院重症监护病房的脓毒症患者分为生存组30例,死亡组16例,分别检测血小板计数(PLT)、D-二聚体(DD)、凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FBG),分析比较两组患者的差异及主要凝血指标与病情严重度(APACHEII评分)的关系。结果:脓毒症患者死亡组与生存组比较血小板计数减少(P<0.05)、活化部分凝血活酶时间延长(P<0.01)、D-二聚体升高(P<0.01)、纤维蛋白原降低(P<0.01),PLT、APTT、DD与APACHEII评分有相关性。结论:脓毒症时存在凝血功能紊乱,动态监测其凝血指标对判断患者的预后及评估病情严重程度有重要意义。 Objective: To investigate the relationship between coagulation disorders and severity and prognosis in sepsis. Methods: All the patients were divided into 2 groups:survival(n=30) and death(n=16). Levels of platelet count (PLT),D-dimer(DD),prothrombin time (PT),thrombin time (TT),activated partial thromboplastin time (APTT) and fibrinogen (FBG) were measured in all patients at the admission day. The differences of coagulation markers between the two groups were analyzed and the relationship between the coagulation markers and APACHE Ⅱ score were studied. Results: Platelet count was decreased(P 〈 0.05),so was FBG(P 〈 0.01) and DD elevated obviously in death groups, APTT was prolonged in the death group, these changes were closely correlated with the APACHE Ⅱ score. Conclusions: The are the dysfunctions of coagulation in the patients with sepsis, PIT, APTT, DD is associated with the prognosis and severity of sepsis.
作者 刘毅 王洪霞
出处 《岭南急诊医学杂志》 2007年第2期92-93,共2页 Lingnan Journal of Emergency Medicine
  • 相关文献

参考文献2

二级参考文献12

  • 1American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med,1992, 20 (6): 864- 874.
  • 2Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23 (10): 1638- 1652.
  • 3Mammen EF. Disseminated intravascular coagulation (DIC). Clin Lab Sci, 2000, 13 (4): 239- 245.
  • 4Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644- 1655.
  • 5ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost, 1999, 82 (2): 713-717.
  • 6Brun - Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors,and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA, 1995, 274 (12): 968-974.
  • 7Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro - organism. Crit Care Med, 2004 ,8(2):82-90.
  • 8Levi M, de Jonge E, van der Poll T, et al. Novel approaches to the management of disseminated intravascular coagulation. Crit Care Med,2000, 28 (9 Suppl): 20-24.
  • 9Creasey AA, Chang AC, Feigen L, et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest, 1993, 91 (6): 2850-2860.
  • 10Coughlin SR. Thrombin signalling and protease - activated receptors.Nature, 2000, 407 (6801): 258 - 2864. 12 Paw linshi R,Mackman N. Tissue factor, coagulation protease, and proteaseactivated receptors in endotoxemia and sepsis. Crit Care Med, 2004,32 (5 suppl): 293 - 297.

共引文献85

同被引文献23

  • 1王红,张淑文,任爱民,张丽霞,王超,黄樱,苏艳丽,王宝恩.重度脓毒症凝血功能紊乱与病情严重度及预后的关系[J].中华急诊医学杂志,2005,14(10):804-806. 被引量:54
  • 2王洪霞,张璐.危重病患者血小板水平与APACHEⅡ评分的关系[J].岭南急诊医学杂志,2006,11(4):271-272. 被引量:1
  • 3Rintala E,Irjala K,Nikoskelainen J.Value of measurement of C -reactive protein in febrile patients with hematological malignancies[J].Eur J Clin Microbiol Infect Dis,1992,11 (11):973 -8.
  • 4Hamalainen S,Kuittinen T,Matinlauri I,et al.Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy:causes and consequences[J].Leukemia and Lymphoma,2008,49 (3):495 - 501.
  • 5Jantunen E,Itala M,Lehtinen T,et al.Early treatment -related mortality in adult autologous stem cell transplant recipients:a nation -wide survey of 1482 transplanted patients[J].European Journal of Haematology,2006,76 (3):245-50.
  • 6Persson L,Engervall P,Magnuson A,et al.Use of Inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia[J].Scandinavian Journal of Infectious Diseases,2004,36 (5):365-71.
  • 7Zeerleder S,Hack C E,Wuillemin W A.Disseminated intravascular coagulation in sepsis[J].Chest,2005,128(4):2 864 -75.
  • 8Esmon CT.The interactions between inflammation and coagulation[J].British Journal of Haematology,2005,131(4):417-30.
  • 9Hunault-Berger M,Chevallier P,Delain M,et al.Changes in antithrombin and fibrinogen levels during induction chemotherapy with L -asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma,Use of supportive coagulation therapy and clinical outcome:the CAPELAL study[J].Haematologica,2008,93 (10):1 488 -94.
  • 10Delves P J,Roitt I M.The immune system[J].New England Journal of Medicine 2000,343(2):37 -49.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部